"If you’re diagnosed with cancer, life changes suddenly. Providence Sacred Heart Medical Center can guide you through this challenging time. We treat all types of cancer and help you and your family with all aspects of a cancer diagnosis. We offer leading-edge technology and the most advanced treatments for fighting cancer while recognizing that having cancer can affect your emotional, spiritual and financial well-being in addition to your physical health. We treat you holistically and tailor our services to meet all your needs. You get the benefit of a team of cancer specialists who work together to ensure you get the best possible care. We’re here for you from screening and diagnosis to treatment and beyond."

During the past decade, Providence Cancer Center at Sacred Heart Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 23 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Cancer Center at Sacred Heart Medical Center" #1 sponsor was "Children's Oncology Group" with 27 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Center at Sacred Heart Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Children's Cancer and Leukaemia Group" with 1 trials as a collaborator and "Children's Oncology Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Providence Cancer Center at Sacred Heart Medical Center" are "Sarcoma" (9 trials), "Breast Cancer" (8 trials), "Leukemia" (7 trials), "Neuroblastoma" (5 trials) and "Lung Cancer" (4 trials). Many other conditions were trialed in "Providence Cancer Center at Sacred Heart Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Cancer Center at Sacred Heart Medical Center" are "Drug" (39 trials), "Biological" (17 trials), "Procedure" (16 trials), "Radiation" (14 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (14 trials), "etoposide" (13 trials), "doxorubicin hydrochloride" (12 trials), "vincristine sulfate" (11 trials) and "radiation therapy" (10 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cancer Center at Sacred Heart Medical Center" are 42 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Cancer Center at Sacred Heart Medical Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Providence Cancer Center at Sacred Heart Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cancer Center at Sacred Heart Medical Center, 4 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".